[Translation] Evaluating the efficacy and safety of SHR8058 eye drops in the treatment of dry eye associated with Meibomian gland dysfunction - a multicenter, randomized, double-blind, saline parallel-controlled phase III clinical trial
以0.6%氯化钠溶液作对照,评价 QID 给药方案下 SHR8058 滴眼液治疗睑板腺功能障碍(MGD)相关干眼病的症状和体征的有效性。
[Translation] To evaluate the efficacy of SHR8058 eye drops in the treatment of symptoms and signs of meibomian gland dysfunction (MGD)-related dry eye under QID dosing regimen with 0.6% sodium chloride solution as control.